Maximus, Inc. (NYSE:MMS – Get Free Report) insider Michelle Link sold 1,610 shares of Maximus stock in a transaction that occurred on Wednesday, October 1st. The stock was sold at an average price of $90.86, for a total value of $146,284.60. Following the transaction, the insider owned 13,508 shares of the company’s stock, valued at $1,227,336.88. This represents a 10.65% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Maximus Trading Down 0.0%
Shares of Maximus stock opened at $91.25 on Friday. The company has a debt-to-equity ratio of 0.91, a current ratio of 2.27 and a quick ratio of 2.27. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $93.73. The company has a market capitalization of $5.14 billion, a P/E ratio of 16.80 and a beta of 0.57. The business has a 50 day moving average price of $85.06 and a 200 day moving average price of $75.34.
Maximus (NYSE:MMS – Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The health services provider reported $2.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.77. Maximus had a return on equity of 24.44% and a net margin of 5.83%.The firm had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.29 billion. During the same period in the previous year, the firm posted $1.74 EPS. The company’s quarterly revenue was up 2.5% compared to the same quarter last year. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. Sell-side analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current fiscal year.
Institutional Trading of Maximus
Wall Street Analyst Weigh In
MMS has been the subject of several research reports. Weiss Ratings restated a “hold (c+)” rating on shares of Maximus in a research report on Saturday, September 27th. Zacks Research upgraded Maximus from a “hold” rating to a “strong-buy” rating in a report on Tuesday, August 26th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Maximus presently has a consensus rating of “Buy” and an average target price of $90.00.
Read Our Latest Stock Report on MMS
About Maximus
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
See Also
- Five stocks we like better than Maximus
- Most active stocks: Dollar volume vs share volume
- After Trump Deal, Can Meta Stock Withstand TikTok’s Onslaught?
- What is the Nasdaq? Complete Overview with History
- Alphabet: After Its Best Quarter in Decades, Is It Time to Buy?
- Ride Out The Recession With These Dividend Kings
- Forget Airlines—These Trucking Stocks Are Shifting Into High Gear
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.